A detailed history of Fcf Advisors LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Fcf Advisors LLC holds 38,961 shares of CORT stock, worth $2.82 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
38,961
Holding current value
$2.82 Million
% of portfolio
0.45%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$67.17 - $83.9 $2.62 Million - $3.27 Million
38,961 New
38,961 $3.24 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.74B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Fcf Advisors LLC Portfolio

Follow Fcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fcf Advisors LLC with notifications on news.